| Cycloalkyl pyrimidines as ferroportin inhibitors |
2022-10-28 |
2022-11-08 |
|
| Tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl) … |
2022-8-29 |
2022-10-01 |
|
| Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl) … |
2022-8-05 |
2022-12-01 |
|
| Substituted benzaldehyde compounds and methods for their use in increasing … |
2022-8-02 |
2022-8-28 |
|
| Process for preparation of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin … |
2022-6-17 |
2022-10-13 |
|
| Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h- … |
2022-5-13 |
2022-6-02 |
|
| Solid forms of a modulator of hemoglobin |
2022-5-13 |
2022-11-17 |
|
| Methods of making a modulator of hemoglobin |
2022-5-13 |
2022-11-17 |
|
| Methods of administering voxelotor |
2022-5-12 |
2022-7-01 |
|
| Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin- … |
2022-3-30 |
2022-6-14 |
|
| Pyrrolidine-pyrazoles as pyruvate kinase activators |
2022-2-07 |
2022-8-25 |
|
| Compounds and uses thereof for the modulation of hemoglobin |
2022-1-03 |
2022-4-21 |
|
| Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl) … |
2021-12-22 |
2022-4-14 |
|
| Azaindole compounds as histone methyltransferase inhibitors |
2021-8-06 |
2021-12-02 |
|
| Urea derivatives as pyruvate kinase activators |
2021-8-03 |
2022-2-10 |
|
| 2 ‐ formyl ‐ 3 ‐ hydroxyphenyloxymethyl compounds capable of modulating … |
2021-6-18 |
2021-6-30 |
|
| Thieno pyrimidines as ferroportin inhibitors |
2021-4-28 |
2021-11-04 |
|
| Methods of use for pyrimidines as ferroportin inhibitors |
2021-4-28 |
2021-11-04 |
|
| CYCLOALKYLATED PYRIMIDINES AS FERROPORTIN INHIBITORS |
2021-4-28 |
2022-7-27 |
|
| Pyrrolidine-pyrazoles as pyruvate kinase activators |
2021-3-31 |
2021-10-07 |
|
| Modulators of hemoglobin |
2021-3-26 |
2021-10-07 |
|
| Histone methyltransferase inhibitors |
2020-11-04 |
2021-4-15 |
|
| Compounds and uses thereof for the modulation of hemoglobin |
2020-9-21 |
2021-8-26 |
|
| Compounds and uses thereof for the modulation of hemoglobin |
2020-6-12 |
2020-7-02 |
|
| Tricyclic compounds as histone methyl-transferase inhibitors |
2020-2-06 |
2020-3-31 |
|
| Ferroportin inhibitors and methods of use |
2019-12-12 |
2021-10-20 |
|
| INHIBITORS OF FERROPORTIN AND ITS USE FOR THE TREATMENT OF DISEASES RELATED TO … |
2019-12-12 |
2021-8-25 |
|
| HEMOGLOBIN MODULATORS |
2019-11-19 |
2021-7-14 |
|
| HEMOGLOBIN MODULATORS |
2019-10-01 |
2021-5-19 |
|
| Modulators of hemoglobin |
2019-10-01 |
2020-8-01 |
|
| Substituted heteroaryl aldehyde compounds and methods for their use in … |
2019-7-23 |
2020-6-18 |
|
| Compounds and uses thereof for the modulation of hemoglobin |
2019-6-19 |
2019-10-03 |
|
| Compounds and uses thereof for the modulation of hemoglobin |
2019-4-12 |
2020-3-12 |
|
| Compounds and uses thereof for modulation of hemoglobin |
2018-9-07 |
2018-11-29 |
|
| TRICYCLIC COMPOUNDS AS INHIBITORS OF HISTONE METHYL TRANSFERASE |
2018-8-14 |
2019-10-23 |
|
| Tricyclic compounds as histone methyltransferase inhibitors |
2018-8-13 |
2020-11-19 |
|
| Tricyclic compounds as Histone Methyltransferase inhibitors. |
2018-8-13 |
2020-10-23 |
|
| Azaindole compounds as histone methyltranferase inhibitors. |
2018-6-07 |
2020-9-18 |
|
| Methods of treatment |
2018-5-16 |
2019-4-18 |
|
| Compounds and uses thereof for the modulation of hemoglobin |
2018-2-06 |
2019-1-10 |
|
| Bridged bicyclic kallikrein inhibitors |
2017-11-08 |
2018-7-12 |
|
| Tablets comprising 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-YL) Pyridin-3-YL) … |
2017-10-12 |
2020-12-31 |
|
| TABLETS THAT INCLUDE 2-HIDROXI-6 - ((2- (1-ISOPROPIL-1H-PIRAZOL-5-IL) PIRIDIN-3 … |
2017-10-12 |
2019-4-17 |
|
| Compounds and uses thereof for the modulation of hemoglobin |
2017-8-18 |
2018-7-05 |
|
| PIRIDINE AND PIRAZOL COMPOUNDS AND THEIR USES FOR HEMOGLOBIN MODULATION |
2017-6-06 |
2018-9-26 |
|
| Substituted benzaldehyde compounds and methods for their use in increasing … |
2017-5-31 |
2021-4-30 |
|
| Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-pyridin- … |
2017-5-11 |
2022-5-27 |
|
| Compounds and uses thereof for the modulation of hemoglobin |
2017-3-24 |
2017-12-14 |
|
| HISTONE METHYLTRANSPHERASA INHIBITORS |
2017-2-17 |
2018-5-23 |
|
| Histone methyltransferase inhibitors |
2017-2-16 |
2018-2-16 |
|
| Dosing regimens for 2-Hydroxy-6-((2-(1Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl) … |
2016-12-02 |
2019-10-28 |
|
| BICYCLIC CALICREIN INHIBITORS BRIDGED |
2016-6-10 |
2017-8-30 |
|
| Compounds and uses thereof for the modulation of hemoglobin |
2015-12-28 |
2018-5-01 |
2018-5-01 |
| Crystalline polymorphs of the free base of 2?hydroxy?6?((2?(1?isopropyl?1h? … |
2015-7-28 |
2020-7-05 |
2020-7-05 |
| Compounds for treating acute respiratory distress syndrome or a negative effect … |
2015-7-24 |
2016-5-26 |
|
| Compounds and uses thereof for the modulation of hemoglobin |
2015-7-02 |
2019-10-08 |
2019-10-08 |
| Pyrazolopyridine pyrazolopyrimidine and related compounds |
2015-5-04 |
2017-7-04 |
2017-7-04 |
| Tricyclic pyrazolopyridine compounds |
2015-5-04 |
2015-11-12 |
|
| 2-HYDROXI-6 FREE BASE CRYSTALLINE POLYMORPHES - ((2- (1-ISOPROPIL-1H-PIRAZOL-5- … |
2015-2-06 |
2016-7-13 |
|
| CRYSTALLINE ANSOLVATE OF COMPOUND, COMPOSITION AND PHARMACEUTICAL COMPOSITION |
2015-2-05 |
2021-11-30 |
|
| Crystalline polymorphs of the free base of 2hydroxy-6-((2-(1-isopropyl-1H- … |
2015-2-05 |
2017-5-15 |
|
| Crystalline 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy) … |
2014-8-25 |
2016-7-21 |
|
| Crystalline 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy) … |
2014-8-25 |
2015-3-05 |
|
| Formulations comprising wetting agents and compounds for the modulation of … |
2014-8-25 |
2015-3-05 |
|
| COMPOUNDS AND THEIR USES FOR HEMOGLOBIN MODULATION |
2014-4-22 |
2015-12-02 |
|
| Substituted aldehyde compounds and methods for their use in increasing tissue … |
2014-3-14 |
2018-10-16 |
2018-10-16 |
| Compounds and uses thereof for the modulation of hemoglobin |
2014-3-13 |
2018-7-21 |
2018-7-21 |
| Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin |
2014-3-12 |
2015-9-17 |
|
| Compounds and uses thereof for the modulation of hemoglobin. |
2014-3-10 |
2016-12-30 |
|
| Compounds and uses thereof for the modulation of hemoglobin. |
2014-3-10 |
2016-12-30 |
|
| Compounds and uses thereof for the modulation of hemoglobin. |
2014-3-10 |
2016-12-30 |
|
| Compositions and methods for the modulation of hemoglobin (s) |
2014-3-10 |
2014-9-25 |
|
| Compositions and methods for the modulation of hemoglobin (s) |
2014-3-10 |
2016-2-11 |
|
| Compounds and uses thereof for the modulation of hemoglobin. |
2014-3-10 |
2016-12-30 |
|
| 1:1 adducts of sickle hemoglobin |
2014-1-29 |
2016-2-02 |
2016-2-02 |
| 1:1 adducts of sickle hemoglobin |
2014-1-29 |
2015-8-06 |
|
| Ansolvato cristalino de composto, composição e composição farmacêutica |
2015-2-05 |
2021-11-30 |
|